Zolinza with bortezomib provide preliminary anti-tumor activity

Armen Hareyan's picture
Advertisement

Studies of patients with advanced multiple myeloma show that Zolinza with bortezomib provide preliminary anti-tumor activity.

Results from two investigational Phase I trials of ZOLINZA

Advertisement